Structural and biological properties of a papillary component generating a micropapillary component in lung

Tatsuya Nagano1, Genichiro Ishii, Kanji Nagai

  • 1Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.

Insights

Lung adenocarcinoma with micropapillary component (MPC) is aggressive. The papillary component generating MPC shows distinct biological behavior, including increased hypoxia, contributing to poorer patient outcomes.

Area of Science:

  • Pulmonary Pathology
  • Oncology
  • Cancer Biology

Background:

  • Lung adenocarcinoma (LADC) encompasses various subtypes with differing prognoses.
  • The micropapillary component (MPC) is associated with aggressive LADC behavior.
  • Understanding the pathobiology of MPC formation is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the pathobiological characteristics of the papillary component that generates MPC.
  • To compare these characteristics with papillary components that do not generate MPC.
  • To correlate these findings with clinical outcomes in resected primary lung adenocarcinoma.

Main Methods:

  • Retrospective review of 445 resected primary lung adenocarcinomas.
  • Histopathological analysis to identify and classify MPC and papillary components (PC).
  • Immunohistochemical staining for CD34, collagen IV, cleaved caspase 3, E-cadherin, beta-catenin, CD44, and GLUT-1.

Main Results:

  • MPC was exclusively found in adenocarcinomas with a papillary component (228 cases).
  • MPC-positive (MPC(+)) adenocarcinoma showed significantly poorer outcomes than MPC-negative (MPC(-)) cases (P<0.0001).
  • Papillary component generating MPC (PC MPC(+)) exhibited smaller stalk width, lacked fibrovascular stalks and basement membranes, and showed significantly higher GLUT-1 expression (hypoxia marker) compared to PC MPC(-).

Conclusions:

  • The papillary component generating MPC possesses distinct structural and hypoxic characteristics compared to papillary components without MPC.
  • These pathobiological differences in the papillary component are associated with the aggressive behavior and poorer prognosis of MPC(+) lung adenocarcinoma.
  • Findings highlight the importance of evaluating the papillary component's features in predicting LADC aggressiveness.